Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Kisvarda – page 4

175 clinical trials in Kisvarda, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.

Kisvarda at a glance
175
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

175 trials in Kisvarda

Open in trial search

Study on VE303 for Preventing Recurrent C. difficile Infection in Patients

Investigational
Countries:HungaryHungary
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Bacilli, Cluster Xvii, Strain Relative Clostridium_Aq Innocuum, Live
  • Sponsor:Vedanta Biosciences Inc.

Study on the Safety and Benefits of Recombinant Human Plasma Gelsolin for Patients with Moderate-to-Severe Acute Respiratory Distress Syndrome (ARDS)

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Human Plasma Gelsolin, Recombinant
  • Sponsor:Bioaegis Therapeutics Inc.

Study on the Effects of Ficlatuzumab and Cetuximab for Adults with Recurrent or Metastatic HPV-Negative Head and Neck Cancer

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Cetuximab
  • Sponsor:Aveo Pharmaceuticals Inc.

Study on Lisaftoclax and Acalabrutinib for Patients with Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Acalabrutinib
  • Sponsor:Ascentage Pharma Group Inc.

Study on Ibrutinib and Venetoclax for Patients with Untreated Chronic Lymphocytic Leukemia

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Ibrutinib
  • Sponsor:Janssen - Cilag International

Cardiovascular disorder+3

Not yet recruiting

Study of Once‑Weekly Eloralintide (LY3841136 Sodium) in Adults with Obesity or Overweight, Type 2 Diabetes, and High Cardiovascular Risk

Investigational
Countries:HungaryHungary
  • Participants:18–64 years
  • Substances:LY3841136 sodium
  • Sponsor:Eli Lilly & Co.

Atrial fibrillation

Not yet recruiting

Stroke and Systemic Embolism Prevention with REGN7508 and REGN9933 in Adults with Atrial Fibrillation Unsuitable for Oral Anticoagulation (Phase 3)

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:REGN9933
  • Sponsor:Regeneron Pharmaceuticals Inc.

Atrial fibrillation

Not yet recruiting

Prevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Regeneron Pharmaceuticals Inc.

Obesity

Not yet recruiting

KAI-9531 in Adults With Obesity or Overweight and Diabetes

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:HRS 9531
  • Sponsor:Kailera Therapeutics Inc.

Arteriosclerosis

Not yet recruiting

A study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Muvalaplin
  • Sponsor:Eli Lilly & Co.

Psoriatic arthropathy

Not yet recruiting

A study to evaluate the long-term safety and effectiveness of sonelokimab in patients with psoriatic arthritis

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Sonelokimab
  • Sponsor:MoonLake Immunotherapeutics AG

Acute myeloid leukaemia

Not yet recruiting

A Study to Assess Effectiveness of IPN60340 with Drug Combination in Adults with Newly Diagnosed Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:Ipsen Pharma

Other cities in Hungary

The busiest research cities in the country

All 73 cities in Hungary

Clinical research in Kisvarda

What the registry says about research in the country

01 Stroke Prevention & Treatment

Groundbreaking research focusing on ischemic stroke prevention and treatment, evaluating novel therapeutic approaches including oral inhibitors and specialized compounds.

  • Post-stroke Prevention
  • Transient Ischemic Attack Management
  • Blood Clot Prevention

Multiple studies are exploring innovative medications to reduce stroke recurrence risk in high-risk patients.

02 Neurological Imaging

Advanced research in contrast enhancement agents for magnetic resonance imaging, specifically targeting central nervous system pathology assessment.

  • Brain Imaging Advancement
  • Spinal Cord Diagnostics
  • MRI Enhancement Technology

Studies focus on developing safer and more effective contrast agents for neurological diagnosis.

03 Respiratory Medicine

Critical research into treatment options for Acute Respiratory Distress Syndrome, particularly cases resulting from pneumonia and other infections.

  • ARDS Treatment
  • Pneumonia Complications
  • Respiratory Care Innovation

Investigating novel protein-based therapies to improve patient outcomes in severe respiratory conditions.

04 Neuromuscular Disorders

Innovative treatments for lower limb spasticity, particularly focusing on post-stroke and traumatic brain injury complications.

  • Spasticity Management
  • Mobility Enhancement
  • Therapeutic Interventions

Clinical evaluation of specialized toxin treatments for improved muscle control and functionality.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.